Meningococcal ACWY (MenACWY) vaccine
MenACWY protects against four groups of meningococcal bacteria. Meningococcal infection can cause meningitis or septicaemia, so symptoms still need urgent assessment after vaccination.
Sources checkedIrish vaccination figures
Recorded MenACWY vaccine uptake in the school cohort.
HPSC school vaccination uptake workbook, data through 2023/24 (Summary and Trends, national uptake, row 45)Who is offered the vaccine
The HSE school programme offers MenACWY in first year of secondary school. Some people may also be advised to have it because of travel or a medical risk.
What it protects against
The vaccine helps the immune system recognise groups A, C, W and Y. MenB is a different group, for which a separate vaccine is used.
What to know before vaccination
Read the consent information and tell the vaccinator about previous serious reactions or health conditions. Check with the local school team if you are unsure whether an offer applies.
What to expect
The vaccinator checks consent and administers an injection, normally in the upper arm. Ask about documenting the dose and whom to call if you have questions afterwards.
Side effects and follow-up
An aching arm or short-lived fever or headache can occur. Severe allergic symptoms require immediate help. The vaccine cannot protect against every cause of meningitis.
Where to get advice
Contact the school vaccination team about a missed appointment or incomplete record. Seek emergency help if you suspect meningitis or septicaemia, regardless of vaccination history.
Sources and further reading
Use this guide for general information. A clinician can advise on your individual symptoms and care.